Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2002
The purpose of this research study is to determine which of three different dose combinations of tipranavir and ritonavir, when taken with a standard approved anti-HIV drug therapy, is most effective and safe. Tipranavir is an investigational protease inhibitor which has been demonstrated to have in vitro activity against HIV-1.
Epistemonikos ID: d1429cbc6e26f6c445cd1f2ba8fca3d1d72169b9
First added on: Dec 01, 2021